79.85 USD
+0.76
0.96%
At close Nov 19, 4:00 PM EST
After hours
79.85
+0.00
0.00%
1 day
0.96%
5 days
-6.04%
1 month
19.23%
3 months
24.94%
6 months
36.52%
Year to date
131.05%
1 year
143.30%
5 years
354.21%
10 years
896.88%
 

About: RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

Employees: 10,288

0
Funds holding %
of 6,735 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

59% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 32

22% more funds holding in top 10

Funds holding in top 10: 9 [Q2] → 11 (+2) [Q3]

20% more capital invested

Capital invested by funds: $3.63B [Q2] → $4.35B (+$713M) [Q3]

7% more funds holding

Funds holding: 275 [Q2] → 294 (+19) [Q3]

1.18% more ownership

Funds ownership: 83.51% [Q2] → 84.69% (+1.18%) [Q3]

1% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 100

59% less call options, than puts

Call options by funds: $7.5M | Put options by funds: $18.3M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$79
1%
downside
Avg. target
$80
0%
upside
High target
$80
0%
upside

3 analyst ratings

positive
100%
neutral
0%
negative
0%
Truist Securities
David Macdonald
67% 1-year accuracy
29 / 43 met price target
0%upside
$80
Buy
Maintained
23 Sept 2024
Jefferies
Brian Tanquilut
67% 1-year accuracy
6 / 9 met price target
0%upside
$80
Buy
Maintained
19 Sept 2024
Barclays
Andrew Mok
38% 1-year accuracy
14 / 37 met price target
1%downside
$79
Overweight
Upgraded
6 Sept 2024

Financial journalist opinion

Based on 8 articles about RDNT published over the past 30 days

Charts implemented using Lightweight Charts™